Thorne HealthTech Wins 2023 MedTech Breakthrough Award for Best Overall Medical Device Product for Thornes OneDraw Blood Collection Device

THRNDelisted Stock  USD 6.40  0.48  8.11%   
About 55% of Thorne HealthTech's investors are presently thinking to get in. The analysis of current outlook of investing in Thorne HealthTech suggests that some traders are interested regarding Thorne HealthTech's prospects. Thorne HealthTech's investing sentiment overview a quick insight into current market opportunities from investing in Thorne HealthTech. Many technical investors use Thorne HealthTech stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Thorne HealthTech, Inc. , a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that its OneDraw Blood Collection Device has been selected as the Best Overall Medical Device Product in the eighth annual MedTech Breakthrough Awards program. MedTech Breakthrough is an independent market intelligence organization that recognizes the breakthrough companies, individuals, platforms, and products in todays health, fi

Read at finance.yahoo.com
Yahoo News
  

Thorne HealthTech Fundamental Analysis

We analyze Thorne HealthTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Thorne HealthTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Thorne HealthTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash And Equivalents

Cash And Equivalents Comparative Analysis

Thorne HealthTech is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Thorne HealthTech Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Thorne HealthTech stock to make a market-neutral strategy. Peer analysis of Thorne HealthTech could also be used in its relative valuation, which is a method of valuing Thorne HealthTech by comparing valuation metrics with similar companies.

Peers

Thorne HealthTech Related Equities

POSTPost Holdings   0.42   
0%
10.0%
NOMDNomad Foods   0.18   
0%
4.0%
ASBFFAssociated British   0.00   
0%
0%
JJSFJ J   0.40   
9.0%
0%
JBSSJohn B   0.60   
14.0%
0%
NATRNatures Sunshine   0.86   
20.0%
0%
LANCLancaster Colony   1.02   
24.0%
0%
CENTCentral Garden   1.09   
26.0%
0%
CENTACentral Garden   1.11   
26.0%
0%
SMPLSimply Good   1.29   
30.0%
0%
SENEASeneca Foods   2.16   
51.0%
0%
BRBRBellring Brands   2.20   
52.0%
0%
RGFReal Good   4.17   
100.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in Thorne Stock

If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine